PMC:7172841 / 11500-11688 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T50","span":{"begin":126,"end":129},"obj":"Body_part"},{"id":"T51","span":{"begin":141,"end":150},"obj":"Body_part"}],"attributes":[{"id":"A50","pred":"fma_id","subj":"T50","obj":"http://purl.org/sig/ont/fma/fma84795"},{"id":"A51","pred":"fma_id","subj":"T51","obj":"http://purl.org/sig/ont/fma/fma62864"}],"text":"However, patients with pneumonia caused by SARS-CoV-2 at an intermediate immune state maintained their number of molecules of HLA-DR on CD14 monocytes much closer to the healthy condition."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T115","span":{"begin":23,"end":32},"obj":"Disease"},{"id":"T116","span":{"begin":43,"end":51},"obj":"Disease"},{"id":"T117","span":{"begin":43,"end":47},"obj":"Disease"}],"attributes":[{"id":"A115","pred":"mondo_id","subj":"T115","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A116","pred":"mondo_id","subj":"T116","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A117","pred":"mondo_id","subj":"T117","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"However, patients with pneumonia caused by SARS-CoV-2 at an intermediate immune state maintained their number of molecules of HLA-DR on CD14 monocytes much closer to the healthy condition."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T69","span":{"begin":141,"end":150},"obj":"http://purl.obolibrary.org/obo/CL_0000576"}],"text":"However, patients with pneumonia caused by SARS-CoV-2 at an intermediate immune state maintained their number of molecules of HLA-DR on CD14 monocytes much closer to the healthy condition."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T55","span":{"begin":113,"end":122},"obj":"Chemical"},{"id":"T56","span":{"begin":130,"end":132},"obj":"Chemical"}],"attributes":[{"id":"A55","pred":"chebi_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/CHEBI_25367"},{"id":"A56","pred":"chebi_id","subj":"T56","obj":"http://purl.obolibrary.org/obo/CHEBI_73445"}],"text":"However, patients with pneumonia caused by SARS-CoV-2 at an intermediate immune state maintained their number of molecules of HLA-DR on CD14 monocytes much closer to the healthy condition."}

{"project":"LitCovid-sentences","denotations":[{"id":"T94","span":{"begin":0,"end":188},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"However, patients with pneumonia caused by SARS-CoV-2 at an intermediate immune state maintained their number of molecules of HLA-DR on CD14 monocytes much closer to the healthy condition."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T54","span":{"begin":23,"end":32},"obj":"Phenotype"}],"attributes":[{"id":"A54","pred":"hp_id","subj":"T54","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"However, patients with pneumonia caused by SARS-CoV-2 at an intermediate immune state maintained their number of molecules of HLA-DR on CD14 monocytes much closer to the healthy condition."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T210","span":{"begin":43,"end":53},"obj":"SP_7"},{"id":"T211","span":{"begin":73,"end":79},"obj":"UBERON:0002405"},{"id":"T212","span":{"begin":113,"end":122},"obj":"CHEBI:36357;CHEBI:36357"},{"id":"T213","span":{"begin":126,"end":129},"obj":"PR:000029150"},{"id":"T214","span":{"begin":136,"end":140},"obj":"PR:000001889"},{"id":"T215","span":{"begin":141,"end":150},"obj":"CL:0000576"},{"id":"T98663","span":{"begin":14,"end":24},"obj":"GO:0006412"},{"id":"T87532","span":{"begin":28,"end":33},"obj":"UBERON:0001977"},{"id":"T7919","span":{"begin":34,"end":48},"obj":"GO:0019814"},{"id":"T90937","span":{"begin":73,"end":78},"obj":"GO:0071735"},{"id":"T37745","span":{"begin":108,"end":114},"obj":"UBERON:0001969"},{"id":"T25561","span":{"begin":118,"end":126},"obj":"SP_7"},{"id":"T59339","span":{"begin":159,"end":168},"obj":"NCBITaxon:2"}],"text":"However, patients with pneumonia caused by SARS-CoV-2 at an intermediate immune state maintained their number of molecules of HLA-DR on CD14 monocytes much closer to the healthy condition."}

{"project":"LitCovid-PubTator","denotations":[{"id":"431","span":{"begin":136,"end":140},"obj":"Gene"},{"id":"441","span":{"begin":9,"end":17},"obj":"Species"},{"id":"442","span":{"begin":43,"end":53},"obj":"Species"},{"id":"446","span":{"begin":23,"end":32},"obj":"Disease"}],"attributes":[{"id":"A431","pred":"tao:has_database_id","subj":"431","obj":"Gene:929"},{"id":"A441","pred":"tao:has_database_id","subj":"441","obj":"Tax:9606"},{"id":"A442","pred":"tao:has_database_id","subj":"442","obj":"Tax:2697049"},{"id":"A446","pred":"tao:has_database_id","subj":"446","obj":"MESH:D011014"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"However, patients with pneumonia caused by SARS-CoV-2 at an intermediate immune state maintained their number of molecules of HLA-DR on CD14 monocytes much closer to the healthy condition."}